SMOX缺陷小鼠视神经蛋白质组学揭示视神经炎神经炎症与轴突损伤调控因子
本研究在实验性自身免疫性脑脊髓炎(EAE)模型中,比较野生型与SMOX缺陷小鼠视神经的蛋白质组,发现SMOX缺陷可延迟并减轻临床评分,减弱神经炎症通路,恢复细胞骨架和细胞黏附蛋白,并确认RACK1、ACTN4、HMGB1和S100B表达失调,提示SMOX是视神经炎保护视力的潜在治疗靶点。
要点
- SMOX缺陷EAE小鼠临床评分延迟且减轻。
- SMOX缺陷减弱视神经神经炎症通路并恢复细胞骨架与黏附蛋白。
- RACK1、ACTN4、HMGB1和S100B在SMOX缺陷视神经中表达失调。
核心结论
- SMOX通过影响炎症和细胞骨架稳定参与视神经炎,可能成为多发性硬化中保护视力的治疗靶点。
研究设计与样本
- 在野生型和SMOX缺陷小鼠中诱导实验性自身免疫性脑脊髓炎,收集视神经进行液相色谱-串联质谱蛋白质组分析,并行免疫荧光验证。
主要发现
- SMOX缺陷EAE小鼠临床评分延迟且减轻。
- 通路富集分析显示EAE中肌动蛋白细胞骨架调控、紧密连接完整性和血小板活化/聚集等过程受影响。
- 比较蛋白质组与FDR校正通路富集分析表明SMOX缺陷视神经中神经炎症通路减弱。
- SMOX缺陷恢复了神经元完整性所需的关键细胞骨架和细胞黏附蛋白。
- 免疫荧光确认RACK1、ACTN4、HMGB1和S100B表达失调。
临床怎么用
- SMOX可能作为视神经炎神经保护治疗的候选靶点,但尚需临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Visual dysfunction due to optic neuritis (ON) is an early clinical manifestation of multiple sclerosis (MS). ON is characterized by inflammation of the optic nerve, demyelination, axonal damage, and retinal ganglion cell (RGC) loss. Previously, we showed that spermine oxidase (SMOX), a polyamine catabolizing enzyme, modulates visual function in an experimental model of ON. Using proteomic analysis, the present study aimed to identify SMOX-regulated molecular pathways involved in ON-associated visual dysfunction. METHODS: Experimental autoimmune encephalomyelitis (EAE) was induced in wild-type (WT) and SMOX-deficient (Smox KO) mice. Clinical scoring of mice was recorded daily. Optic nerves from WT and Smox KO EAE mice and their controls were collected and analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Pathway enrichment and comparative analyses were performed to identify key processes and pathways regulated by SMOX. Immunofluorescence was performed to detect changes in the expression of key proteins. RESULTS: Smox KO EAE mice showed delayed and reduced clinical scores. Pathway enrichment analysis identified several key processes affected in EAE, including regulation of the actin cytoskeleton, tight junction integrity, and platelet activation/aggregation. The comparative analysis of the WT EAE and Smox KO EAE proteomes, together with false discovery rate (FDR)-corrected pathway enrichment analysis, indicated attenuation of neuroinflammatory pathways in the SMOX-deficient optic nerve. Furthermore, SMOX deficiency restored key cytoskeletal and cellular-adhesion proteins essential for neuronal integrity. Immunofluorescence studies confirmed dysregulation of receptor for activated C kinase 1 (RACK1), actinin alpha 4 (ACTN4), high mobility group box 1 (HMGB1), and S100 calcium-binding protein B (S100B), critical proteins involved in immune signaling, cytoskeletal stability, and inflammation. CONCLUSIONS: These findings indicate the impact of SMOX on inflammation and cytoskeletal stabilization in ON and its potential as a therapeutic target in preserving vision in MS.
引用
- Henry Ojo H, Liu F, Alanazi AH, et al. Proteomic Profiling of Optic Nerves From SMOX-Deficient Mice Identifies Regulators of Neuroinflammation and Axonal Damage in Optic Neuritis. Invest Ophthalmol Vis Sci. 2026. PMID: 42390174. doi:10.1167/iovs.67.8.4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。